AI-generated summary
The authors studied cancer-associated fibroblasts treated with photobiomodulation at 660 and 980 nm, with or without pirfenidone, then applied the conditioned media to cancer cells. They report that photobiomodulation reduced pirfenidone's anti-fibrogenic effects on these fibroblasts, increased their viability, and preserved their ability to promote cancer cell migration and clonogenic potential. The authors caution that photobiomodulation should be used carefully against cancer until underlying mechanisms are clarified.
- Who or what was studied
- Cancer-associated fibroblasts and cancer cells grown in vitro (cell culture study)
- Wavelengths
- 660, 980 nm
- Limits stated in the abstract
- The study is an in vitro cell culture study using conditioned media, and the abstract states that underlying mechanisms and treatment protocols require further investigation.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 980 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Low-level laser therapy, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.